Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.

Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.

Item
http://www.wikidata.org/entity/Q34313853
Myosin binding protein C: implications for signal-transductionDesensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.Cardiomyocyte-specific expression of CRNK, the C-terminal domain of PYK2, maintains ventricular function and slows ventricular remodeling in a mouse model of dilated cardiomyopathy.Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approachEffects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.SERCA2 Haploinsufficiency in a Mouse Model of Darier Disease Causes a Selective Predisposition to Heart FailureTrimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-CTropomyosin dephosphorylation results in compensated cardiac hypertrophyMicroarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued by a phospholamban knockout.Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathyp90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in α-tropomyosin Glu180Gly transgenic miceTherapeutic Strategies Targeting Inherited Cardiomyopathies.C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.
P2860

Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.

Item
http://www.wikidata.org/entity/Q34313853
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@ast
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@en
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@nl
type
label
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@ast
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@en
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@nl
prefLabel
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@ast
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@en
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Neonatal gene transfer of Serc ...... l hypertrophic cardiomyopathy.
@en
P2093
P2860
P304
P31
P356
10.1016/J.YJMCC.2010.09.010
P433
P478
P577
P5875
P698
P932